quinoxalines has been researched along with Leukemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, P; Dai, Y; Deng, DH; Dong, HQ; Liang, SJ; Sun, N; Xu, YL | 1 |
| Bifulco, G; Bruno, I; Chini, MG; Colarusso, E; Ferraro, MG; Gazzillo, E; Irace, C; Lauro, G; Piccolo, M; Pierri, M; Terracciano, S | 1 |
| Bigat, D; Desplat, V; Enriquez, E; Guillon, J; Lucas, R; Marchivie, M; Moreau, S; Pinaud, N; Ronga, L; Rossi, F; Routier, S; Rubio, S; Savrimoutou, S; Sonnet, P; Vincenzi, M | 1 |
| Desplat, V; Fabre, SB; Gay, A; Godde, F; Guillon, J; Jarry, C; Macky, G; Massip, S; Moreau, S; Mossalayi, D; Thiolat, D | 1 |
| Karthikeyan, C; Moorthy, NS; Trivedi, P | 1 |
| Belisle-Fabre, S; de Moor, L; Déléris, G; Desplat, V; Guillon, J; Jarry, C; Lucas, R; Massip, S; Moreau, S; Mossalayi, DM; Sonnet, P; Thiolat, D; Uranga, J | 1 |
| Hazeldine, ST; Horwitz, JP; Kessel, D; Polin, L; Reiners, JJ | 1 |
| Artz, A; Bivins, C; Borthakur, G; Cortes, J; Faderl, S; Giles, FJ; Godley, L; Larson, RA; Odenike, O; Ratain, MJ; Ravandi, F; Rich, E; Stock, W; Undevia, SD; Verstovsek, S; Wierda, W; Zhang, Y | 1 |
1 trial(s) available for quinoxalines and Leukemia
| Article | Year |
|---|---|
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Leukemia; Male; Maximum Tolerated Dose; Middle Aged; Quinoxalines; Remission Induction; Stereoisomerism; Treatment Outcome | 2008 |
7 other study(ies) available for quinoxalines and Leukemia
| Article | Year |
|---|---|
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells.
Topics: Apoptosis; Caspase 3; Cell Cycle; Cell Cycle Checkpoints; Cell Proliferation; Humans; K562 Cells; Leukemia; Pore Forming Cytotoxic Proteins; Pyroptosis; Quinoxalines; Spiro Compounds | 2022 |
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9.
Topics: Adaptor Proteins, Signal Transducing; Binding Sites; DNA-Binding Proteins; Humans; Leukemia; Quinoxalines; Structure-Activity Relationship; Transcription Factors | 2023 |
Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Leukemia; Models, Molecular; Molecular Structure; Quinoxalines; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |
Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II.
Topics: Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Design; Esters; Female; Humans; Leukemia; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Quinoxalines | 2010 |
Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives.
Topics: Antineoplastic Agents; Drug Design; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Intercalating Agents; Leukemia; Molecular Structure; Quantitative Structure-Activity Relationship; Quinoxalines | 2010 |
Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inhibitory Concentration 50; Leukemia; Models, Molecular; Molecular Structure; Quinoxalines; Structure-Activity Relationship | 2011 |
The role of autophagy in the death of L1210 leukemia cells initiated by the new antitumor agents, XK469 and SH80.
Topics: Androstadienes; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein 7; Caspase 3; Cell Cycle; Cell Size; Cell Survival; Cytoplasmic Vesicles; Enzyme Activation; Gene Silencing; Kinetics; Leukemia; Mice; Microtubule-Associated Proteins; Peptide Hydrolases; Propionates; Quinoxalines; Tumor Stem Cell Assay; Vacuoles; Wortmannin | 2007 |